Drug Enforcement Administration February 2020 – Federal Register Recent Federal Regulation Documents

Registration Requirements for Narcotic Treatment Programs With Mobile Components
Document Number: 2020-03627
Type: Proposed Rule
Date: 2020-02-26
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) proposes to revise the existing regulations for narcotic treatment programs (NTPs) to allow a mobile component associated with the registered program to be considered a coincident activity. The NTP registrants that operate or wish to operate mobile components (in the state that the registrant is registered in) to dispense narcotic drugs in schedules II-V at a remote location for the purpose of maintenance or detoxification treatment would not be required to obtain a separate registration for a mobile component. This proposed rule would waive the requirement of a separate registration at each principal place of business or professional practice where controlled substances are dispensed for those NTPs with mobile components that fully comply with the requirements of the proposed rule, once finalized. These revisions to the regulations are intended to make maintenance or detoxification treatments more widely available, while ensuring that safeguards are in place to reduce the likelihood of diversion.
Jaime C. David, M.D.; Decision and Order
Document Number: 2020-03626
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturers of Marihuana: Irvine Labs, Inc.
Document Number: 2020-03623
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic classes of controlled substances listed in schedule I. Prior to making decisions on this and other pending applications, DEA intends to promulgate regulations that govern the program of growing marihuana for scientific and medical research under DEA registration.
Importer of Controlled Substances Application: PerkinElmer, Inc.
Document Number: 2020-03620
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Research Triangle Institute
Document Number: 2020-03619
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Stepan Company
Document Number: 2020-03618
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals, Inc.
Document Number: 2020-03617
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Synthcon, LLC
Document Number: 2020-03616
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
Document Number: 2020-03612
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Document Number: 2020-03611
Type: Notice
Date: 2020-02-24
Agency: Drug Enforcement Administration, Department of Justice
Solomon Adu-Beniako, M.D.; Decision and Order
Document Number: 2020-01971
Type: Notice
Date: 2020-02-03
Agency: Drug Enforcement Administration, Department of Justice
Theresa L. Wendt, N.P.; Decision and Order
Document Number: 2020-01970
Type: Notice
Date: 2020-02-03
Agency: Drug Enforcement Administration, Department of Justice
Kambiz Haghighi, M.D.; Decision and Order
Document Number: 2020-01969
Type: Notice
Date: 2020-02-03
Agency: Drug Enforcement Administration, Department of Justice
Andrzej Kazimierz Zielke, M.D.; Decision and Order
Document Number: 2020-01968
Type: Notice
Date: 2020-02-03
Agency: Drug Enforcement Administration, Department of Justice
Shelton W. Barnes, M.D.; Decision and Order
Document Number: 2020-01967
Type: Notice
Date: 2020-02-03
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturers of Marihuana: Spocannabis LLC
Document Number: 2020-01966
Type: Notice
Date: 2020-02-03
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic classes of controlled substances listed in schedule I. Prior to making decisions on this and other pending applications, DEA intends to promulgate regulations that govern the program of growing marihuana for scientific and medical research under DEA registration.
Bulk Manufacturer of Controlled Substances Application: IsoSciences, LLC
Document Number: 2020-01960
Type: Notice
Date: 2020-02-03
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Noramco Inc.
Document Number: 2020-01959
Type: Notice
Date: 2020-02-03
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Stepan Company
Document Number: 2020-01958
Type: Notice
Date: 2020-02-03
Agency: Drug Enforcement Administration, Department of Justice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.